Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

GL803a

Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases/80 cores, replacing GL803
Unstained: $255.00 Add to Cart
H&E (GL803as*): $255.00 Add to Cart

Microarray Panel:Brain tumor and adjacent normal tissue microarray, containing 55 cases of brain astrocytoma，3 brain oligo-astrocytoma, 10 brain oligodendroglioma, 3 brain medulloblastoma, 4 brain ependymoma, plus 5 brain adjacemt normal tissue, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Type †
A1 1 F 14 Brain Astrocytoma 1 Malignant
A2 2 F 15 Brain Astrocytoma 1 Malignant
A3 3 M 41 Brain Astrocytoma 2 Malignant
A4 4 F 34 Brain Astrocytoma 2 Malignant
A5 5 M 73 Brain Astrocytoma 2 Malignant
A6 6 M 36 Brain Astrocytoma 2 Malignant
A7 7 M 51 Brain Astrocytoma 2 Malignant
A8 8 F 16 Brain Astrocytoma 2 Malignant
A9 9 M 25 Brain Astrocytoma 2 Malignant
A10 10 M 33 Brain Astrocytoma 2 Malignant
B1 11 M 62 Brain Astrocytoma (tumoral necrosis) – Malignant
B2 12 F 39 Brain Astrocytoma 1 Malignant
B3 13 M 53 Brain Astrocytoma 3 Malignant
B4 14 M 57 Brain Astrocytoma 3 Malignant
B5 15 M 52 Brain Astrocytoma 3 Malignant
B6 16 M 41 Brain Glioblastoma 4 Malignant
B7 17 M 59 Brain Astrocytoma (sparse) 4 Malignant
B8 18 F 36 Brain Astrocytoma 3–4 Malignant
B9 19 M 41 Brain Astrocytoma 3–4 Malignant
B10 20 M 45 Brain Glioblastoma 4 Malignant
C1 21 M 57 Brain Glioblastoma 4 Malignant
C2 22 F 19 Brain Glioblastoma 4 Malignant
C3 23 M 66 Brain Glioblastoma 4 Malignant
C4 24 M 43 Brain Glioblastoma 4 Malignant
C5 25 F 22 Brain Glioblastoma 4 Malignant
C6 26 M 49 Brain Glioblastoma 4 Malignant
C7 27 F 64 Brain Astrocytoma 3–4 Malignant
C8 28 M 60 Brain Astrocytoma 3–4 Malignant
C9 29 F 43 Brain Glioblastoma 4 Malignant
C10 30 F 27 Brain Astrocytoma 3–4 Malignant
D1 31 F 66 Brain Glioblastoma 4 Malignant
D2 32 F 50 Brain Glioblastoma 4 Malignant
D3 33 F 31 Brain Glioblastoma 4 Malignant
D4 34 F 52 Brain Astrocytoma 3–4 Malignant
D5 35 M 58 Brain Glioblastoma 4 Malignant
D6 36 F 41 Brain Glioblastoma 4 Malignant
D7 37 M 24 Brain Glioblastoma 4 Malignant
D8 38 F 42 Brain Glioblastoma 4 Malignant
D9 39 F 59 Brain Glioblastoma 4 Malignant
D10 40 M 71 Brain Glioblastoma 4 Malignant
E1 41 F 37 Brain Glioblastoma 4 Malignant
E2 42 F 10 Brain Glioblastoma 4 Malignant
E3 43 F 44 Brain Glioblastoma 4 Malignant
E4 44 M 43 Brain Glioblastoma 4 Malignant
E5 45 F 6 Brain Glioblastoma 4 Malignant
E6 46 M 64 Brain Glioblastoma 4 Malignant
E7 47 M 25 Brain Glioblastoma 4 Malignant
E8 48 M 43 Brain Glioblastoma 4 Malignant
E9 49 M 20 Brain Glioblastoma 4 Malignant
E10 50 F 68 Brain Glioblastoma 4 Malignant
F1 51 M 30 Brain Glioblastoma 4 Malignant
F2 52 M 35 Brain Glioblastoma 4 Malignant
F3 53 M 42 Brain Glioblastoma 4 Malignant
F4 54 M 43 Brain Glioblastoma 4 Malignant
F5 55 M 55 Brain Glioblastoma 4 Malignant
F6 56 M 46 Brain Oligo-astrocytoma – Malignant
F7 57 M 45 Brain Oligo-astrocytoma – Malignant
F8 58 F 48 Brain Oligo-astrocytoma – Malignant
F9 59 F 50 Brain Oligodendroglioma 1 Malignant
F10 60 F 46 Brain Oligodendroglioma 2 Malignant
G1 61 M 41 Brain Oligodendroglioma 2 Malignant
G2 62 M 29 Brain Oligodendroglioma 2 Malignant
G3 63 F 30 Brain Oligodendroglioma 2 Malignant
G4 64 M 39 Brain Oligodendroglioma 2 Malignant
G5 65 M 40 Brain Anaplastic oligodendroglioma – Malignant
G6 66 M 55 Brain Anaplastic oligodendroglioma – Malignant
G7 67 M 43 Brain Anaplastic oligodendroglioma – Malignant
G8 68 M 37 Brain Malignant oligodendroglioma 3 Malignant
G9 69 F 14 Brain Medulloblastoma – Malignant
G10 70 M 11 Brain Medulloblastoma – Malignant
H1 71 M 3 Brain Medulloblastoma – Malignant
H2 72 M 41 Brain Ependymoma – Malignant
H3 73 F 4 Brain Ependymoma – Malignant
H4 74 M 55 Brain Malignant ependymoma – Malignant
H5 75 M 41 Brain Anaplastic ependymoma – Malignant
H6 76 F 30 Brain Cancer adjacent normal brain tissue – NAT
H7 77 F 49 Brain Cancer adjacent normal brain tissue – NAT
H8 78 M 30 Brain Cancer adjacent normal brain tissue – NAT
H9 79 M 39 Brain Cancer adjacent normal brain tissue – NAT
H10 80 M 52 Brain Cancer adjacent normal brain tissue – NAT
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.


Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal